bpc 157 fda banned The pro-peptide stacked advisory committee voted to lift the ban for -157, and others, as expected. This ban lifting is baseless and will give the public a sense of legitimacy for BPC 157 Banned: Key Facts

General Safety Profile Based on the preclinical dataset and the limited human exposure data: No prominent signal of hepatic, renal, or hematological toxicity at tested doses No prominent cardiovascular safety flag Pregnancy and lactation as with most research compounds, safety not established Long-term effects not characterized What Clinicians Should Actually Tell Patients For patients asking about 5-amino-1MQ, a reasonable response framework: What the compound is: A research-stage small molecule inhibiting NNMT with promising preclinical fat loss data

Nor would I accept out of date (oral) medication from pharmacy/hospital, for the same reasons

Just this year, the FDA approved Jesduvroq tablets (daprodustat) as the first oral treatment for anemia caused by chronic kidney disease, for adults who have been receiving dialysis for at least four months

The honest bottom line is simply that the evidence isn't there yet